Portuguese | English





Pressione Enter para iniciar a Busca.





Volume 114, Nº 1, January 2020

   

DOI: https://doi.org/10.36660/abc.20190111

REVIEW ARTICLE

Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction: State of the Art and Prospects for the Future

Sara Lopes Fernandes

Rita Ribeiro Carvalho

Luís Graça Santos

Fernando Montenegro Sá

Catarina Ruivo

Sofia Lázaro Mendes

Hélia Martins

João Araujo Morais



Figure 1 – Pathophysiology of HFpEF - possible mechanisms involved. AF: atrial fibrillation; CAD: coronary artery disease; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; HFpEF: heart failure with preserved ejection fraction; HT: arterial hypertension; NO-cGMP-PKG: nitric oxide, reduced cyclic guanosine monophosphate and protein kinase G; PH: pulmonary hypertension; RAAS: renin-angiotensin-aldosterone system; RV: right ventricle.





Keywords: Heart Failure/physiopathology; Heart Failure/diagnosis; Heart Failure/drug therapy; Systolic Volume; Heart Failure/ complications.